Trial Profile
A PROSPECTIVE STUDY TO ASSESS THE INTERACTION BETWEEN PATIENT GENOTYPE AND ROSTAFUROXIN EFFECTS ON ARTERIAL BLOOD PRESSURE AND KIDNEY FUNCTION IN NEVER-TREATED HYPERTENSIVE TYPE 2 DIABETES PATIENTS (AN OPEN LABEL STUDY WITH BLINDED PATIENT GENOTYPE) [STUDIO DELL'INTERAZIONE TRA GENOTIPO ED EFFETTO DELLA ROSTAFUROXINA SU PRESSIONE ARTERIOSA E FUNZIONALITA' RENALE IN PAZIENTI CON DIABETE TIPO 2 ED IPERTENSIONE ARTERIOSA MAI TRATTATA]
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2014
Price :
$35
*
At a glance
- Drugs Rostafuroxin (Primary)
- Indications Hypertension in diabetes
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PAIR
- 26 Feb 2014 New trial record